ClinicalTrialsFinder

Breast Cancer Recurrent Clinical Trials in Fairfax, Virginia

1 recruitingFairfax, Virginia

Showing 1–1 of 1 trials

Recruiting
Phase 1

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

Ovarian CancerAdvanced Solid TumorsBreast Cancer Recurrent+1 more
Accent Therapeutics90 enrolled5 locationsNCT06799065